Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak
- PMID: 33336506
- DOI: 10.1002/ccd.29433
Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak
Abstract
Background: During COVID-19 pandemic in Spain, elective procedures were canceled or postponed, mainly due to health care systems overwhelming.
Objective: The objective of this study was to evaluate the consequences of interrupting invasive procedures in patients with chronic cardiac diseases due to the COVID-19 outbreak in Spain.
Methods: The study population is comprised of 2,158 patients that were pending on elective cardiac invasive procedures in 37 hospitals in Spain on the 14th of March 2020, when a state of alarm and subsequent lockdown was declared in Spain due to the COVID-19 pandemic. These patients were followed-up until April 31th.
Results: Out of the 2,158 patients, 36 (1.7%) died. Mortality was significantly higher in patients pending on structural procedures (4.5% vs. 0.8%, respectively; p < .001), in those >80 year-old (5.1% vs. 0.7%, p < .001), and in presence of diabetes (2.7% vs. 0.9%, p = .001), hypertension (2.0% vs. 0.6%, p = .014), hypercholesterolemia (2.0% vs. 0.9%, p = .026) [Correction added on December 23, 2020, after first online publication: as per Dr. Moreno's request changes in p-values were made after original publication in Abstract.], chronic renal failure (6.0% vs. 1.2%, p < .001), NYHA > II (3.8% vs. 1.2%, p = .001), and CCS > II (4.2% vs. 1.4%, p = .013), whereas was it was significantly lower in smokers (0.5% vs. 1.9%, p = .013). Multivariable analysis identified age > 80, diabetes, renal failure and CCS > II as independent predictors for mortality.
Conclusion: Mortality at 45 days during COVID-19 outbreak in patients with chronic cardiovascular diseases included in a waiting list due to cancellation of invasive elective procedures was 1.7%. Some clinical characteristics may be of help in patient selection for being promptly treated when similar situations happen in the future.
Keywords: catheterization; diagnostic; percutaneous coronary intervention (PCI); transcatheter valve implantation (TVI).
© 2020 Wiley Periodicals LLC.
References
REFERENCES
-
- World Health Organization. Coronavirus disease 2019 (COVID-19) situation report - 78. Geneva: WHO; 2020.
-
- Johns Hopkins Coronavirus Resource Center. Johns Hopkins Coronavirus Resource Center; 2020. https://coronavirus.jhu.edu/https://www.gouvernement.fr/info-coronavirus....
-
- Romaguera R, Cruz-González I, Jurado-Román A, et al. Considerations on the invasive management of ischemic and structural heart disease during the COVID-19 coronavirus outbreak. Consensus statement of the interventional cardiology association and the ischemic heart disease and acute cardiac Care Association of the Spanish Society of cardiology. REC Interv Cardiol. 2020;2:106-111.
-
- Moreno R, Ojeda S, Romaguera R, Jimenez-Quevedo P, Cruz-González I. Transcatheter aortic valve replacement during COVID-19 pandemic. Recommendations from the Association of Interventional Cardiology of the Spanish Society of Cardiology (ACI-SEC). REC: Interv Cardiol. 2020;2:230-231.
-
- Rodríguez-Leor O, Cid-Álvarez B, Ojeda S, et al. Impact of the COVID-19 pandemic on interventional cardiology activity in Spain. REC: Interv Cardiol. 2020;2:82-89.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
